Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Contributor

Renee Kaswan

Dr. Renee Kaswan is founder of the non-profit www.IPAdvocate.org, former research professor at the University of Georgia and inventor of the billion-dollar drug Restasis®.

No contributions

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »